CBD Life Sciences (OTCMKTS:CBDL) stock is trading a lower in the first hour of trading on Tuesday after the news.
Market Reaction:
As of 10:50, CBDL stock moved down 8.33% to $0.0005 with more than 100.40 million shares, compared to its average volume of 407.93 million shares. The stock has moved within a range of $0.0005 – 0.0006 after opening the trade at $0.0006.
Major Trigger:
CBD Life Sciences, Inc. (CBDL) Launches 2nd Retail Location
Key Highlights:
- CBDL announced that the Grand Opening of their 2nd retail location that took place this past weekend on Saturday June 12th was a success!
- “We had our official Grand Opening of The CBD Vault on June 12th and we could not be any happier with the positive response we received from all the customers. We sold out of all 4 of our new strains of Delta-8 cartridges (Strawberry Cough, Blue Dream, Pineapple Express, Zkittles) within the first hour of opening,” said Lisa Nelson, President & CEO. Lisa Nelson also stated, “Over 200 customers came in and out to celebrate and it turned out to be an incredibly good event and we are beyond satisfied with the results!”
- CBD Life Sciences Inc. is looking forward to opening a 3rd & 4th Retail location in Sedona and Las Vegas as time goes on. The company is also inquiring for a recreational over the counter marijuana facility as well. This will be significant as far as expansion and revenue go and CBD Life Sciences Inc. will keep the public informed moving forward.
Key Quote:
According to Shaun Passley, PhD, CEO of Epazz, Inc., “We are gratified to announce that our team is now working overtime to cater to different organizations that request customized DeskFlex anti-COVID features and help them return to work or back to school safely.”
){kind=link}